GR3020312T3 - Anticoagulant combination of laci and sulfated polysaccharides - Google Patents

Anticoagulant combination of laci and sulfated polysaccharides

Info

Publication number
GR3020312T3
GR3020312T3 GR960401682T GR960401682T GR3020312T3 GR 3020312 T3 GR3020312 T3 GR 3020312T3 GR 960401682 T GR960401682 T GR 960401682T GR 960401682 T GR960401682 T GR 960401682T GR 3020312 T3 GR3020312 T3 GR 3020312T3
Authority
GR
Greece
Prior art keywords
laci
sulfated polysaccharides
combination
anticoagulant
anticoagulant combination
Prior art date
Application number
GR960401682T
Other languages
Greek (el)
English (en)
Inventor
Tze-Chein Wun
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of GR3020312T3 publication Critical patent/GR3020312T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR960401682T 1990-08-27 1996-06-20 Anticoagulant combination of laci and sulfated polysaccharides GR3020312T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57308390A 1990-08-27 1990-08-27

Publications (1)

Publication Number Publication Date
GR3020312T3 true GR3020312T3 (en) 1996-09-30

Family

ID=24290576

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960401682T GR3020312T3 (en) 1990-08-27 1996-06-20 Anticoagulant combination of laci and sulfated polysaccharides

Country Status (10)

Country Link
EP (1) EP0473564B1 (ja)
JP (1) JPH0733336B2 (ja)
AT (1) ATE135585T1 (ja)
CA (1) CA2049873C (ja)
DE (1) DE69118056T2 (ja)
DK (1) DK0473564T3 (ja)
ES (1) ES2085462T3 (ja)
GR (1) GR3020312T3 (ja)
IE (1) IE913004A1 (ja)
PT (1) PT98779B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629287A (en) * 1991-01-18 1997-05-13 University College London Depot formulations
US5610148A (en) * 1991-01-18 1997-03-11 University College London Macroscopically oriented cell adhesion protein for wound treatment
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
DE69530084T2 (de) * 1994-07-07 2004-02-05 Washington University Methode zur verminderung arterieller stenose
JP3779728B2 (ja) * 1994-08-05 2006-05-31 カイロン コーポレイション 組織因子活性インヒビターの産生
US5589359A (en) * 1994-08-05 1996-12-31 Chiron Corporation Chimeric proteins
DE69635051T2 (de) 1995-06-07 2006-06-14 Chiron Corp Methode zur lösung, reinigung und rückfaltung von protein
AU759412B2 (en) * 1995-06-07 2003-04-17 G.D. Searle & Co. Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
AU2003200506B2 (en) * 1995-06-07 2007-01-18 G.D. Searle Llc Method of solubilizing, purifying and refolding protein and compositions comprising proteins and solubilizing agents
US5772629A (en) * 1995-10-23 1998-06-30 Localmed, Inc. Localized intravascular delivery of TFPI for inhibition of restenosis in recanalized blood vessels
JP2000507204A (ja) * 1995-12-18 2000-06-13 ステイヒテイング・サンキン・ブロードボールジーニング Ｃ１―インヒビターの補体及び血液凝固阻害特性の強化
EP1446140A4 (en) 2001-10-15 2007-03-07 Novartis Vaccines & Diagnostic TREATMENT OF HEAVY PNEUMONIA BY ADMINISTRATION OF TFPI (TISSUE FACTOR PATHWAY INHIBITOR)
WO2005019265A1 (en) 2003-08-13 2005-03-03 Chiron Corporation Improved method of purifying tfpi and tfpi analogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87172A (en) * 1987-07-23 1994-12-29 Univ Washington Method of isolating highly purified tissue factor inhibitor
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co cDNA of human tissue factor inhibitor
DE69117545T2 (de) * 1990-01-25 1996-10-31 Univ Washington Faktor X-LACI-Hybridprotein

Also Published As

Publication number Publication date
DK0473564T3 (da) 1996-04-15
EP0473564B1 (en) 1996-03-20
ES2085462T3 (es) 1996-06-01
JPH04257524A (ja) 1992-09-11
PT98779B (pt) 1999-06-30
DE69118056D1 (de) 1996-04-25
DE69118056T2 (de) 1996-10-24
CA2049873C (en) 2001-12-04
CA2049873A1 (en) 1992-02-28
EP0473564A1 (en) 1992-03-04
IE913004A1 (en) 1992-03-11
JPH0733336B2 (ja) 1995-04-12
ATE135585T1 (de) 1996-04-15
PT98779A (pt) 1992-07-31

Similar Documents

Publication Publication Date Title
GR3020312T3 (en) Anticoagulant combination of laci and sulfated polysaccharides
SE9101957L (sv) Blandningar av polysackarider med laag molekylvikt samt framstaellning och anvaendning av desamma
AU5841090A (en) Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same
MD1224C2 (ro) Utilizare a analogilor nucleozidici cu 1,3-oxatiolan în tratamentul hepatitei B
NO985978L (no) Insulinpreparater som inneholder karbohydrater
DE68903134D1 (de) Intraokulares vorderkammerimplantat.
BR9408585A (pt) Artigo tendo porção de cintura frontal porção de cintura posterior e porção intermediária interligando as porções de cintura frontal e posterior e artigo de fixação
NZ333925A (en) Use of heparin or heparan sulphate in combination with chitosan for the prevention or treatment of infections caused by herpes virus
ATE10340T1 (de) Stabilisierung der aktivitaet des faktors viii im blutplasma.
ES2094848T3 (es) Agente de crecimiento del hepatocito.
NO962752D0 (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
GR3024588T3 (en) Use of modified heparin cofactor II
PH27568A (en) Lactamimides in the treatment of drug-resistant protozoal infections
AU590191B2 (en) Process for the pasteurization of plasma or concentrates of blood coagulation factors II, VII, IX and X
ZA907808B (en) Combination preparation having antithrombotic action
ZA943868B (en) Novel polysaccharides having high antithrombotic and anticoagulant activity
FR2662092B1 (fr) Ski.
DK0984787T3 (da) Anvendelse af lavmolekylære hepariner til forebyggelse og behandling af hjerneødemer
AU6879091A (en) Protease nexin i/dextran sulfate anticoagulant
EP0712864A3 (en) Non-absorbable synthetic sulfated polysaccharides
GR3005823T3 (ja)
ITMI912602A0 (it) Flangia di un subbio, particolarmente di un subbio di ordito o di catena
DK0427402T3 (da) Anvendelse af cyclodextriner og derivater deraf
Ashizuka Mechanical Properties of Phosphate Glasses and Ceramics
GB9016609D0 (en) Compositions for the active or prophylactic treatment of intravascular coagulation or thrombosis